MedTrace Logo

Reborn Lifestyle Adjustment Program

NCT06608043 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2024-09-23

No results posted yet for this study

Summary

The aim of this study is to investigate the effects of the reborn lifestyle regulation program on physical activity, fatigue level, pain, mental health burden and quality of life in breast cancer patients.

Conditions

Interventions

BEHAVIORAL

Reborn lifestyle adjustment program

The sessions are based on the 'Do Live Well' model, Kolb's Experiential Learning Theory, and CBT-based problem-solving skills. Introduction to the Reborn Lifestyle: Core principles of the Reborn Program for building a healthy lifestyle during and after breast cancer. Physical Activity: The role of physical activity during treatment and exercises to boost energy levels. Fatigue Management: Scientific methods for managing fatigue during and after treatment. Pain Management: Effective techniques to reduce pain and improve quality of life. Mental Health Burden: Strategies to alleviate mental health burdens and cope with stress. Quality Sleep: Practical methods to improve sleep patterns and achieve quality rest. Preventive Rehabilitation Approaches: Essential rehabilitation strategies to protect health and reduce recurrence risk. The study will be conducted online, with evaluations and sessions via Zoom before and after the 12-week modules.

PROCEDURE

Conventional Physiotherapy and Occupational Therapy

Patients in the control group will continue conventional medical treatments, occupational therapy and physiotherapy sessions.

Sponsors & Collaborators

  • Atlas University

    lead OTHER

Principal Investigators

  • Sena Ondes, MSc · Atlas University

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-01
Primary Completion
2025-02-01
Completion
2025-08-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06608043 on ClinicalTrials.gov